NCT04089228

Brief Summary

The aim of this research is to see the effects of kinesio taping after integrated neuromuscular inhibition technique on pain, disability, pain-pressure threshold and muscle length in patients with upper trapezius trigger points. There will be two groups experimental and control. One study group will receive kinesiotaping after integrated neuromuscular inhibition technique and the other group will only receive integrated neuromuscular inhibition technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2019

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 4, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 13, 2019

Completed
Last Updated

September 13, 2019

Status Verified

September 1, 2019

Enrollment Period

5 months

First QC Date

September 4, 2019

Last Update Submit

September 11, 2019

Conditions

Keywords

Myofascial trigger pointsKinesiotapingIntegrated Neuromuscular Inhibition Technique

Outcome Measures

Primary Outcomes (3)

  • Neck disability index

    Changes from the baseline, The NDI is a modification of the neck disability index and it was developed by Vernon and Mior. It was designed to measure the neck pain and disability over time. It consists of 10 items, five parts sections. At the end, score is calculated by dividing the obtained score by total 50 multiplied by 100.

    4th Day

  • Pain-Pressure threshold (PPT)

    Changes from the baseline, Pain-pressure threshold was measured with the help of an algometer.

    4th day

  • NPRS

    Changes from the baseline, Numeric Pain rating scale is a scale for pain intensity starting from 0-10. Where 0 indicates no pain and 10 indicate severe pain.

    4th Day

Secondary Outcomes (1)

  • Muscle length measure

    4th Day

Study Arms (2)

Kinesiotape Group and INIT

EXPERIMENTAL

Kinesiotaping and Integrated Neuromuscular Inhibition Technique (KT + INIT )

Other: KinesiotapingOther: Integrated Neuromuscular Inhibition Technique

INIT Group

ACTIVE COMPARATOR

Integrated Neuromuscular Inhibition Technique (INIT)

Other: Integrated Neuromuscular Inhibition Technique

Interventions

Total of 4 sessions on upper trapezius trigger points on alternate days.

Kinesiotape Group and INIT

Sustain Pressure. Strain Counter-strain (for 90 sec) Passive Isometric Relaxation (PIR) (6-10 sec hold, 4 reps)

INIT GroupKinesiotape Group and INIT

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Upper Trapezius Active or latent trigger points
  • Limited range of motion (cervical Side Bending)

You may not qualify if:

  • Radiculopathies
  • Malignancy
  • Infection
  • Trauma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Riphah International University

Islamabad, Federal, Pakistan, 44000, Pakistan

Location

Related Publications (8)

  • Vazquez-Delgado E, Cascos-Romero J, Gay-Escoda C. Myofascial pain syndrome associated with trigger points: a literature review. (I): Epidemiology, clinical treatment and etiopathogeny. Med Oral Patol Oral Cir Bucal. 2009 Oct 1;14(10):e494-8. doi: 10.4317/medoral.14.e494.

    PMID: 19680218BACKGROUND
  • Lluch E, Nijs J, De Kooning M, Van Dyck D, Vanderstraeten R, Struyf F, Roussel NA. Prevalence, Incidence, Localization, and Pathophysiology of Myofascial Trigger Points in Patients With Spinal Pain: A Systematic Literature Review. J Manipulative Physiol Ther. 2015 Oct;38(8):587-600. doi: 10.1016/j.jmpt.2015.08.004. Epub 2015 Sep 19.

    PMID: 26387860BACKGROUND
  • Lavelle ED, Lavelle W, Smith HS. Myofascial trigger points. Anesthesiol Clin. 2007 Dec;25(4):841-51, vii-iii. doi: 10.1016/j.anclin.2007.07.003.

    PMID: 18054148BACKGROUND
  • Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Physician. 2002 Feb 15;65(4):653-60.

    PMID: 11871683BACKGROUND
  • Shah JP, Gilliams EA. Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome. J Bodyw Mov Ther. 2008 Oct;12(4):371-384. doi: 10.1016/j.jbmt.2008.06.006. Epub 2008 Aug 13.

    PMID: 19083696BACKGROUND
  • Cerezo-Tellez E, Torres-Lacomba M, Mayoral-Del Moral O, Sanchez-Sanchez B, Dommerholt J, Gutierrez-Ortega C. Prevalence of Myofascial Pain Syndrome in Chronic Non-Specific Neck Pain: A Population-Based Cross-Sectional Descriptive Study. Pain Med. 2016 Dec;17(12):2369-2377. doi: 10.1093/pm/pnw114. Epub 2016 Jun 20.

    PMID: 28025371BACKGROUND
  • Vernon H, Schneider M. Chiropractic management of myofascial trigger points and myofascial pain syndrome: a systematic review of the literature. J Manipulative Physiol Ther. 2009 Jan;32(1):14-24. doi: 10.1016/j.jmpt.2008.06.012.

    PMID: 19121461BACKGROUND
  • Bubnov RV. Evidence-based pain management: is the concept of integrative medicine applicable? EPMA J. 2012 Oct 22;3(1):13. doi: 10.1186/1878-5085-3-13.

    PMID: 23088743BACKGROUND

Study Officials

  • Abdul Ghafoor Sajjad, PhD*

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
this study is randomized control trail, participants are randomly allocated through sealed envelope method
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2019

First Posted

September 13, 2019

Study Start

February 1, 2019

Primary Completion

June 20, 2019

Study Completion

June 30, 2019

Last Updated

September 13, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations